The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.

J Immunol Res · 2015 · PMC4578753 · PMID 26436101

Europe PMC DOI

hedged sentence

0.4641

closest p · 9.3× alpha

0.4641

boldest claim

The sentences

did not reach statistical significancep = 0.4641not close (p > 0.1)

The IL-17 expression in both CD4+CD161+ and CD4+CD161− T cells was higher in pSS patients than in healthy controls, but it did not reach statistical significance (IL-17, pSS versus HC: CD161− 2.53 ± 1.29 versus 1.86 ± 1.39, p = 0.4641; CD161+ 5.29 ± 2.37 versus 3.98 ± 2.61, p = 0.4318).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.